Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brain

Journal of Neural Transmission

Volumn 107, Issue 3, 2000, Pages 335-341

  Mogi, M ^a   Togari, A ^a   Kondo, T ^b   Mizuno, Y ^b   Komure, O ^c   Kuno, S ^c   Ichinose, H ^d   Nagatsu, T ^d  

^a AICHI GAKUIN UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UTANO NATIONAL HOSPITAL   (Japan)

^d FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Brain; Caspase 1; Caspase 3; Parkinson's disease; Tumor necrosis factor receptor R1 (p55)

Indexed keywords

CASPASE; CASPASE 3; INTERLEUKIN 1BETA CONVERTING ENZYME; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; APOPTOSIS; ARTICLE; CAUDATE NUCLEUS; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FRONTAL CORTEX; GLIA; HUMAN; HUMAN TISSUE; MALE; NERVE CELL; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

EID: 0034023082     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050028     Document Type: Article

References (26)

1. Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y (1997a) Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 12: 25-31
2. Anglade P, Vyas S, Hirsch EC, Agid Y (1997b) Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging. Histol Histopathol 12: 603-610
3. Banati RB, Daniel SE, Blunt SB (1998) Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov Disord 13: 221-227
4. Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, Hirsch EC (1994) Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci Lett 172: 151-154
5. Boonman Z, Isacson O (1999) Apoptosis in neuronal development and transplantation: role of caspases and trophic factors. Exp Neurol 156: 1-15
6. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
7. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van-Ness K, Greenstreet TA, March CJ, Kronheim SR, Druck T, Cannizzaro LA, Huebner K, Black R A (1992) Molecular cloning of the interleukin-1β converting enzyme. Science 256: 97-100
8. Enari M, Talanian RV, Wong WW, Nagata S (1996) Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380: 723-726
9. Friedlander RM, Brown RH, Gagliardini V, Wang J, Yuan J (1997) Inhibition of ICE slows ALS in mice. Nature 388: 31
10. Jellinger KA (1999) Is there apoptosis in Lewy body disease? Acta Neuropathol (Berl) 97:413-115
11. Kawahara A, Kobayashi T, Nagata S (1998) Inhibition of Fas-induced apoptosis by Bcl-2. Oncogene 17: 2549-2554
12. Kim TW, Pettingell WH, Jung YK, Kovacs DM, Tanzi RE (1997) Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277: 373-376
13. Kosel S, Egensperger R, von-Eitzen U, Mehraein P, Graeber MB (1997) On the question of apoptosis in the parkinsonian substantia nigra. Acta Neuropathol (Berl) 93: 105-108
14. Kumar S (1995) ICE-like proteases in apoptosis. Trends Biochem Sci 20: 198-202
15. Marshall KA, Daniel SE, Cairns N, Jenner P, Halliwell B ( 1997) Upregulation of the antiapoptotic protein Bcl-2 may be an early event in neurodegeneration: studies on Parkinson's and incidental Lewy body disease. Biochem Biophys Res Commun 240: 84-87
16. Masliah E, Mallory M, Alford M, Tanaka S, Hansen LA ( 1998) Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer disease. J Neuropathol Exp Neurol 57: 1041-1052
17. Mochizuki H, Goto K, Mori H, Mizuno Y (1996) Histochemical detection of apoptosis in Parkinson's disease. J Neurol Sci 137: 120-123
18. Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T (1994) Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165: 208-210
19. Mogi M, Harada M, Kondo T, Riederer P, Nagatsu T (1995) Brain β2-microglobulin levels are elevated in the striatum in Parkinson's disease. J Neural Transm [P-D Sect] 9: 87-92
20. Mogi M, Harada M, Kondo T, Mizuno Y, Narabayashi H, Riederer P, Nagatsu T (1996a) bcl-2 protein is increased in the brain from parkinsonian patients. Neurosci Lett 215: 137-139
21. Mogi M, Harada M, Kondo T, Mizuno Y, Narabayashi H, Riederer P, Nagatsu T (1996b) The soluble form of Fas molecule is elevated in parkinsonian brain tissues. Neurosci Lett 220: 195-198
22. Nagata S (1997) Apoptosis by death factor. Cell 88: 355-365
23. Okahashi N, Koide M, Jimi E, Suda T, Nishihara T (1998) Caspases (interleukin-1β-converting enzyme family proteases) are involved in the regulation of the survival of osteoclasts. Bone 23: 33-41
24. Stadelmann C, Bruck W, Bancher C, Jellinger K, Lassmann H (1998) Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J Neuropathol Exp Neurol 57: 456-464
25. Stern G (1996) Parkinson's disease: the apoptosis hypothesis. Adv Neurol 69: 101-107
26. Wullner U, Kornhuber J, Weller M, Schulz JB, Loschmann PA, Riederer P, Klockgether T (1999) Cell death and apoptosis regulating proteins in Parkinsons disease-a cautionary note. Acta Neuropathol (Berl) 97: 408-412